This bill amends the reporting requirements for the Therapeutic Cannabis Medical Oversight Board by enhancing the content of its annual report. Specifically, it mandates that the report, which is due by January 1 each year, must now include detailed documentation of the board's reviews of both currently approved and additional qualifying medical conditions. The report must also present the board's findings and recommendations, along with citations to the medical and scientific evidence that informed their decisions.

The legal language changes include the insertion of new requirements for the report, which aim to provide greater transparency and accountability regarding the board's evaluations and recommendations concerning therapeutic cannabis use. There are no deletions from the current law noted in this bill. The act is set to take effect 60 days after its passage.

Statutes affected:
Introduced: 126-X:12
As Amended by the Senate: 126-X:12
SB400 text: 126-X:12